Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Background: Prenatal exposure to perfluoroalkyl substances (PFAS) has been previously associated with preeclampsia, although findings are mixed with respect to the direction and magnitude of effect. To our knowledge, no studies have examined associations between PFAS and preeclampsia subtypes, which may have distinct etiologies. Objective: We examined associations between PFAS, any preeclampsia diagnosis, and early- and late-onset preeclampsia. In addition, we estimated associations between PFAS and the angiogenic biomarkers soluble fms-like tyrosine kinase-1 (sFLT-1) and placental growth factor (PlGF), which provide an estimate of pro- and anti-angiogenic activity within the placenta. Methods: This case–control study (n=75 cases, n=75 controls) was sampled from the LIFECODES birth cohort. Nine legacy PFAS were quantified in maternal plasma from early pregnancy (median= 10 wk) and angiogenic biomarkers were quantified in maternal plasma from four study visits (median= 10, 18, 26, and 35 wk). Logistic regression was used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) of the association between an interquartile range (IQR)-increase in PFAS and preeclampsia outcomes. Linear regression was used to estimate associations between an IQR-increase in PFAS and concentrations of angiogenic biomarkers. Results: Both perfluorodecanoic acid (OR= 1.64, 95% CI: 1.08, 2.47) and perfluorooctanesulfonic acid (OR= 1.60, 95% CI: 1.06, 2.43) were associated with higher odds of late-onset preeclampsia. Associations tended to be below the null for early-onset preeclampsia, although findings were imprecise. Few associations were noted between PFAS and angiogenic biomarkers. Discussion: Maternal PFAS concentrations were associated with higher odds of late-onset preeclampsia. Heterogeneity of preeclampsia should be considered in future studies because populations may have different distributions of disease subtypes. https://doi.org/10.1289/EHP9091
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101 · cited 1×
“These factors are released by the placenta into the maternal circulation, giving an indication of the balance of anti-angiogenic (i.e., sFLT-1) to pro-angiogenic (i.e., PlGF) activity within the placenta (Maynard et al. 2003; McElrath et al. 2012).”
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Estimation of Average Concentration in the Presence of Nondetectable Values
Hornung, R. W., & Reed, L. D. (1990) · Applied Occupational and Environmental Hygiene · doi:10.1080/1047322x.1990.10389587 · Cited by 3,495
Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60279-6 · Cited by 2,850
Sunderland, E. M., Hu, X. C., Dassuncao, C., Tokranov, A. K., Wagner, C. C., & Allen, J. G. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-018-0094-1 · Cited by 2,786
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552
Onuegbu, A. J., Olisekodiaka, J. M., Udo, J. U., Umeononihu, O., Amah, U. K., Okwara, J. E., & Atuegbu, C. (2015) · Medical Principles and Practice · doi:10.1159/000381778 · Cited by 2,044
The Uterine Spiral Arteries In Human Pregnancy: Facts and Controversies
Pijnenborg, R., Vercruysse, L., & Hanssens, M. (2006) · Placenta · doi:10.1016/j.placenta.2005.12.006 · Cited by 1,205
Cited by
Public Health Risks of PFAS-Related Immunotoxicity Are Real
Bline, A. P., DeWitt, J. C., Kwiatkowski, C. F., Pelch, K. E., Reade, A., & Varshavsky, J. (2024) · Current Environmental Health Reports · doi:10.1007/s40572-024-00441-y · Cited by 149
Taibl, K. R., Schantz, S., Aung, M. T., Padula, A., Geiger, S., Smith, S., Park, J.-S., Milne, G. L., Robinson, J. F., Woodruff, T. J., et al. (2022) · Environment International · doi:10.1016/j.envint.2022.107541 · Cited by 113
Taibl, K. R., Dunlop, A. L., Barr, D. B., Li, Y., Eick, S. M., Kannan, K., Ryan, P. B., Schroder, M., Rushing, B. R., Fennell, T. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38710-3 · Cited by 122
Padula, A. M., Ning, X., Bakre, S., Barrett, E. S., Bastain, T., Bennett, D. H., Bloom, M. S., Breton, C. V., Dunlop, A. L., Eick, S. M., et al. (2023) · Environmental Health Perspectives · doi:10.1289/ehp10723 · Cited by 119
Self-citationPFAS Exposures and the Human Metabolome: A Systematic Review of Epidemiological Studies
India-Aldana, S., Yao, M., Midya, V., Colicino, E., Chatzi, L., Chu, J., Gennings, C., Jones, D. P., Loos, R. J. F., Setiawan, V. W., et al. (2023) · Current Pollution Reports · doi:10.1007/s40726-023-00269-4 · Cited by 114
Metadata
- Authors
- Bommarito, P. A., Ferguson, K. K., Meeker, J. D., McElrath, T. F., & Cantonwine, D. E.
- Affiliations
- National Institutes of Health (US)
- University of Michigan (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Cantonwine, David E.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-10
- Volume
- 129
- Issue
- 10
- Pages
- 107004-107004
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- PMC
- PMC8509361
- OpenAlex
- W3206454742
- Semantic Scholar
- 784af87465cf506d3c197e653379c74ac4c0dda1
- Cited by
- 70
- References
- 69
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 15 · 2023: 13 · 2022: 13
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- Locations
- Environmental Health Perspectives (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences (ZIAES103321, P30ES017885)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- perfluorinated compounds, preeclampsia, late-onset preeclampsia, early-onset preeclampsia, perfluorodecanoic acid, PFOS, angiogenic biomarkers, soluble fms-like tyrosine kinase-1, placental growth factor, maternal plasma, prenatal exposure, placental angiogenesis
- MeSH terms
- Placenta Growth Factor, Female, Fluorocarbons, Humans, Pre-Eclampsia, Pregnancy, Biomarkers, Case-Control Studies, Vascular Endothelial Growth Factor Receptor-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk. https://app.cochat.ai/papers/10.1289/ehp9091
- The paper
- Bommarito, P. A., Ferguson, K. K., Meeker, J. D., McElrath, T. F., & Cantonwine, D. E. (2021). Maternal Levels of Perfluoroalkyl Substances (PFAS) during Early Pregnancy in Relation to Preeclampsia Subtypes and Biomarkers of Preeclampsia Risk. Environmental Health Perspectives. https://doi.org/10.1289/ehp9091
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.